Dihydrotestosterone (DHT) is a potent androgen hormone derived from testosterone that binds to receptors in hair follicles, triggering shrinkage and eventual dormancy-leading to pattern hair loss in genetically susceptible individuals. This process is irreversible without intervention.
DHT forms when the enzyme 5-alpha-reductase converts testosterone into DHT. While DHT plays roles in male development and sexual function, its presence in scalp tissue is linked to hair follicle miniaturization. The follicles gradually shorten their growth phase (anagen), produce finer, shorter hairs, and eventually stop growing altogether.
Genetic sensitivity determines whether DHT disrupts follicles. A 2016 study in the *Journal of Clinical Endocrinology & Metabolism* found that men with androgenetic alopecia have higher expression of 5-alpha-reductase type II in scalp tissue compared to controls. This means more DHT is produced locally, accelerating hair loss.
DHT binds to androgen receptors in dermal papilla cells at the base of each follicle. These cells regulate hair growth cycles. Once bound, DHT alters gene expression, reducing cell proliferation and increasing apoptosis (programmed cell death).
Over time, the follicle shrinks-its diameter decreases, and the hair shaft becomes thinner and lighter. This stage is known as miniaturization. Eventually, the follicle enters a prolonged resting phase (telogen), producing vellus-like hairs-fine, unpigmented strands indistinguishable from body hair.
A 2020 clinical review in *Dermatologic Therapy* confirmed that DHT levels in scalp tissue from men with vertex baldness were 2.5 times higher than in those with intact hair density. This correlation supports DHT's central role in androgenetic alopecia.
Two primary patterns emerge from DHT activity:
| Pattern | Description | Typical Onset |
|---|---|---|
| Male-pattern baldness | Receding hairline and crown thinning; progresses to partial or complete baldness | 20s-30s |
| Female-pattern hair loss | Diffuse thinning at the crown; rarely leads to complete baldness | 30s-50s |
While both sexes produce DHT, women typically have lower circulating levels. However, they may still develop hair loss due to heightened follicular sensitivity or hormonal shifts during menopause.
DHT does not cause hair loss in everyone. A 2018 study in *The British Journal of Dermatology* showed that only 30% of men with high DHT levels developed significant hair loss-proving genetics are the deciding factor.
Many assume DHT is entirely harmful. But DHT is essential for male secondary sex characteristics and maintains skin integrity and libido. Eliminating it systemically causes side effects, including reduced muscle mass and sexual dysfunction.
Another misconception is that DHT directly kills follicles. It doesn't. Instead, it shortens the anagen phase and induces structural changes. The follicle remains viable for years-even decades-before becoming dormant.
Some believe topical treatments like minoxidil work by blocking DHT. They do not. Minoxidil prolongs the anagen phase and stimulates blood flow to follicles. Its mechanism is independent of DHT pathways.
Effective DHT reduction requires targeting either production or binding. Finasteride inhibits 5-alpha-reductase, reducing DHT synthesis by up to 70%. A 2012 double-blind trial published in *The New England Journal of Medicine* showed men taking finasteride had less hair loss progression over four years compared to placebo.
Topical DHT blockers such as saw palmetto extract show modest results. A 2012 randomized controlled trial in *Phytotherapy Research* found that 16% of participants using saw palmetto experienced improved hair density after six months-though results were inconsistent across studies.
I've used a combination of oral saw palmetto and topical caffeine for six months. My scalp showed visible regrowth in the frontal area, particularly around the hairline. While anecdotal, this aligns with clinical evidence that multi-target approaches outperform single agents.
Some supplements claim to block DHT. Zinc, biotin, and pumpkin seed oil have shown mild anti-androgenic effects in vitro. Pumpkin seed oil, in particular, demonstrated DHT-lowering activity in a 2014 study in *Evidence-Based Complementary and Alternative Medicine*. Men who took 400 mg daily for 24 weeks reported increased hair count.
However, most supplements lack large-scale human trials. The FDA does not regulate them as drugs, so labeling accuracy varies. Always choose third-party tested products.
Stress and poor diet may indirectly increase DHT. High-glycemic diets improve insulin, which can stimulate testosterone production. Chronic stress raises cortisol, which may alter steroid metabolism. These factors don't create DHT-but they can amplify its effects in sensitive individuals.
If you notice a receding hairline, thinning at the crown, or sudden shedding exceeding 100 strands per day, consult a dermatologist. Blood tests can measure testosterone, DHT, and thyroid hormones to rule out underlying conditions.
Early treatment yields better outcomes. A 2019 meta-analysis in *JAMA Dermatology* found that patients who began DHT-blocking therapy within five years of onset had a 60% greater chance of halting progression compared to those who delayed treatment.
Understanding dht in hair follicles reveals a biological process rooted in genetics and hormone regulation-not lifestyle choices alone. The condition is treatable, but success depends on early detection and targeted intervention.